Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction
NCT ID: NCT03169582
Last Updated: 2017-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
78 participants
INTERVENTIONAL
2016-04-01
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is an interventional study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury
NCT00725790
A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction
NCT00654082
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
NCT00421083
Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy
NCT00895011
Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males
NCT01067391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Avanafil
Clinical evaluation of the two pharmacological interventions (Sildenafil vs Avanafil).
Avanafil
Drug administration (Avanafil)
Sildenafil
Clinical evaluation of the two pharmacological interventions (Sildenafil vs Avanafil)
Sildenafil
Drug administration (Sildenafil)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Avanafil
Drug administration (Avanafil)
Sildenafil
Drug administration (Sildenafil)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Erectile dysfunction
* No Medical Contraindication to use Avanafil and/or Sildenafil
* Able to provide informed consent
* Able to complete questionnaires
Exclusion Criteria
* No spinal cord injury
* Congenital spinal cord injury
* Not able to provide informed consent
* Not able to complete questionnaires
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eduardo Vargas-Baquero
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eduardo Vargas-Baquero
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Nacional de Paraplejicos
Toledo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eduardo Vargas-Baquero, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HNParaplejicos
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.